Erowid References Database
|
Stanford MW.
“Designer drugs: Medical aspects and clinical management”.
Alcoholism Treatment Quarterly. 1988;4(4):97-125.
|
|
Abstract
Discusses designer drugs (i.e., illegally manufactured psychoactive compounds that are chemically manipulated for the consumer) that are currently circulating within the chemically dependent population, including analogs of fentanyl, meperidine, phencyclidine, and MDA/MDMA (93-4-methylenedioxyamphetamine and its N-methyl analog, respectively). Drug classifications, kinetics, central nervous system (CNS) effects, patterns of abuse, and treatment suggestions are outlined for each drug. As no one can attest to the kitchen chemist's knowledge of chemical synthesis, the products' potency, purity, or toxic potentiation for cellular damage is unknown. ((c) 1999 APA/PsycINFO, all rights reserved)
|
| # |
| Submit Comment |
|
[
Cite HTML ]
